Elite Clinical Network, LLC

Based in Nevada, US, and fouded in 1996, Elite Clinical Network offers a diverse range of physician specialities and candidate databases under the close supervision of a professional corporate management team. The company’s integrated platform operates a network of phase I–IV clinical research sites. In September 2023, Surge Private Equity invested USD 200 million in Elite Clinical Network. As of September 2023, the company’s CEO is David Wilson III.

Elite Clinical Network offers a comprehensive suite of services to pharmaceutical sponsors and contract research organizations (CROs) that utilize advanced industry knowledge, practices, and technology to move clinical trials efficiently from mandate to completion across a broad spectrum of therapeutic areas. The company offers the screening of 1-3 subjects on the first day of site activation, meets or exceeds enrollment goals in under six months, and provides real-time quality control with 24-hour Electronic Data Capture (EDC) completion. The firm’s extensive network includes over 100 physician referral practices and facilities, covering a wide range of medical specialities such as cardiology, ophthalmology, gynaecology, and internal medicine. The investment helps the Elite Clinical Network support the next phase of building its national network.